Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
2 selected
)
Type
Guidance (1852)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (598)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (756)
Apply filters
Showing 1 to 50 of 2050
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
3C Patch for treating diabetic foot ulcers
MTG66
7 March 2022
7 March 2022
Ab externo canaloplasty for primary open-angle glaucoma
IPG591
13 September 2017
13 September 2017
Ab interno canaloplasty for open-angle glaucoma
IPG745
22 November 2022
22 November 2022
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal)
TA568
13 March 2019
13 March 2019
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis
TA373
16 December 2015
16 December 2015
Abdominal aortic aneurysm: diagnosis and management
NG156
19 March 2020
19 March 2020
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
TA563
27 February 2019
27 February 2019
Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence
TA810
20 July 2022
20 July 2022
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
TA725
15 September 2021
15 September 2021
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen
TA259
27 June 2012
27 July 2016
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
TA387
27 April 2016
27 July 2016
Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer
TA721
18 August 2021
18 August 2021
Abortion care
NG140
25 September 2019
25 September 2019
Abortion care
QS199
26 January 2021
26 January 2021
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis
TA814
3 August 2022
3 August 2022
Acalabrutinib for treating chronic lymphocytic leukaemia
TA689
21 April 2021
21 April 2021
Acne vulgaris: management
NG198
25 June 2021
7 December 2023
Acute coronary syndromes
NG185
18 November 2020
18 November 2020
Acute coronary syndromes in adults
QS68
5 September 2014
18 November 2020
Acute heart failure
QS103
3 December 2015
3 December 2015
Acute heart failure: diagnosis and management
CG187
8 October 2014
17 November 2021
Acute kidney injury
QS76
22 December 2014
23 March 2023
Acute kidney injury: prevention, detection and management
NG148
18 December 2019
28 September 2023
Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)
QS210
31 October 2023
31 October 2023
Acute upper gastrointestinal bleeding in adults
QS38
30 July 2013
30 July 2013
Acute upper gastrointestinal bleeding in over 16s: management
CG141
13 June 2012
25 August 2016
Acutely ill adults in hospital: recognising and responding to deterioration
CG50
25 July 2007
25 July 2007
Adalimumab and dexamethasone for treating non-infectious uveitis
TA460
26 July 2017
26 July 2017
Adalimumab for the treatment of adults with psoriasis
TA146
25 June 2008
25 June 2008
Adalimumab for treating moderate to severe hidradenitis suppurativa
TA392
22 June 2016
22 June 2016
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
TA455
12 July 2017
12 July 2017
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed
TA715
14 July 2021
14 July 2021
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
TA375
26 January 2016
26 January 2016
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor
TA195
25 August 2010
25 August 2010
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B
TA96
22 February 2006
22 February 2006
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I
DG32
25 April 2018
25 April 2018
Advanced breast cancer: diagnosis and treatment
CG81
23 February 2009
16 August 2017
Advocacy services for adults with health and social care needs
NG227
9 November 2022
9 November 2022
Afamelanotide for treating erythropoietic protoporphyria
HST27
26 July 2023
26 July 2023
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)
TA444
24 May 2017
24 May 2017
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer
TA310
23 April 2014
23 April 2014
Aflibercept for treating choroidal neovascularisation
TA486
1 November 2017
1 November 2017
Aflibercept for treating diabetic macular oedema
TA346
22 July 2015
22 July 2015
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion
TA409
28 September 2016
28 September 2016
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
TA305
26 February 2014
26 February 2014
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy
TA307
25 March 2014
25 March 2014
Aflibercept solution for injection for treating wet age‑related macular degeneration
TA294
24 July 2013
24 July 2013
Age-related macular degeneration
NG82
23 January 2018
23 January 2018
Agomelatine for the treatment of major depressive episodes (terminated appraisal)
TA231
27 July 2011
27 July 2011
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images
DG55
5 July 2023
5 July 2023
Current page
1
2
3
…
41
Page
1
of
41
Next page
Results per page
10
25
50
All
Back to top